Stratec SE (ADR)
General ticker "STSEY" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $1.8B (TTM average)
Stratec SE (ADR) does not follow the US Stock Market performance with the rate: -31.6%.
Estimated limits based on current volatility of 0.0%: low 5.51$, high 5.51$
Factors to consider:
- Company pays dividends (annually): last record date 2025-07-01, amount 0.14$ (Y2.54%)
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [4.56$, 14.00$]
- 2025-12-31 to 2026-12-31 estimated range: [4.44$, 12.23$]
Short-term STSEY quotes
Long-term STSEY plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | €261.91MM | €257.62MM | €250.86MM |
| Operating Expenses | €236.48MM | €229.44MM | €240.18MM |
| Operating Income | €25.43MM | €28.18MM | €10.69MM |
| Non-Operating Income | €-7.21MM | €-6.17MM | €-5.84MM |
| Interest Expense | €3.99MM | €5.90MM | €4.20MM |
| R&D Expense | €8.74MM | €11.61MM | €15.94MM |
| Income(Loss) | €18.23MM | €22.01MM | €4.85MM |
| Taxes | €5.16MM | €5.99MM | €5.09MM |
| Net Income(Loss)* | €13.07MM | €16.02MM | €-0.24MM |
| Stockholders Equity | €233.33MM | €242.53MM | €237.32MM |
| Inventory | €142.62MM | €117.62MM | €109.50MM |
| Assets | €466.58MM | €445.06MM | €425.99MM |
| Operating Cash Flow | €19.43MM | €48.71MM | €-0.43MM |
| Capital expenditure | €17.42MM | €18.19MM | €16.23MM |
| Investing Cash Flow | €-44.16MM | €-15.97MM | €-16.80MM |
| Financing Cash Flow | €35.44MM | €-20.30MM | €-6.30MM |
| Earnings Per Share** | €0.21 | €0.05 | €-0.00 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.